• FirefoxInstall the new Firefox »
  •  Dow Down 0.09% Nasdaq Down 0.15%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    75.60 Down 2.29(2.94%) 12:51PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:77.89
    Open:77.15
    Bid:75.36 x 300
    Ask:75.60 x 100
    1y Target Est:91.11
    Beta:1.67
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:75.09 - 78.36
    52wk Range:35.33 - 93.33
    Volume:184,194
    Avg Vol (3m):522,234
    Market Cap:2.57B
    P/E (ttm):N/A
    EPS (ttm):-4.03
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLVS

    Comparison

    Symbol% ChgMkt Cap
    CLVSDown 2.94%2.57B
    IMMUDown 0.49%380.09M
    LRUSF 0.00%N/A
    THLDDown 1.35%274.22M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):194.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-7.41
    Quarterly EPS Est (Mar-15) :-1.82
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback